Research and experimental development on biotechnology
Visa Information
Licensed Visa Types
skilled worker
First Recorded as Sponsor
July 3, 2025
Annual Issuance Trend
About
We are an Oxford University spin-out developing breakthrough therapies for the treatment of ALS and other neurodegenerative diseases. Our approach builds upon novel protein isoform insights identified using our state-of-the-art technologies including long read sequencing and proprietary bioinformatics pipelines. Our founding team has decades of experience in the field of precision medicines, and we have an unwavering focus on developing novel therapies for patients. We are based in Oxford, UK (www.isogenixtx.com).
Suggest an edit
Latest Jobs (3 days ago) in United Kingdom
Don't let the early bird get the worm! Join our membership and explore more latest jobs!
